In Ex parte Michalek, Attraction No. 2023-004204 (PTAB Dec. 27, 2024), the Patent Trial and Attraction Board (PTAB) evaluated an invention involving medical well being know-how and synthetic intelligence. The PTAB particularly acknowledged that the patent claims at subject recited new details about the nexus between sure biomarkers and improvement of lung most cancers as facilitated by machine studying. In truth, previous to enchantment, the applicant had efficiently overcome all rejections below part 103. However, primarily based on Patent Workplace steering, the PTAB nonetheless decided the claims had been flawed from the attitude of material eligibility. Though the details on this resolution concern medical well being innovation, the choice is useful to tell patent technique for AI enabled innovations throughout varied disciplines and industries.
Trending
- Did You Hear About The New Merger? – See Also
- Gray’s White House Reporter Claims She’s Not a Lizard Person After Weird Glitch in Video
- What Time Does ‘Alien Earth’ Begin Streaming This Week? How To Watch
- Seoul-based Datumo raises $15.5M to take on Scale AI, backed by Salesforce
- Trump takes over police, deploys National Guard in DC: What to know
- Walmart has quietly slashed prices on some of my fave Switch titles
- Hot weather to peak amid water shortage fears
- Pronto’s 10-minute house help pitch sparked a 3.6x valuation jump in just 90 days